Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Operating Margin (2016 - 2020)

Historic Operating Margin for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Q2 2020 value amounting to 399.06%.

  • Avadel Pharmaceuticals' Operating Margin rose 4244100.0% to 399.06% in Q2 2020 from the same period last year, while for Mar 2021 it was 24.76%, marking a year-over-year increase of 160200.0%. This contributed to the annual value of 26.04% for FY2020, which is 667600.0% up from last year.
  • As of Q2 2020, Avadel Pharmaceuticals' Operating Margin stood at 399.06%, which was up 4244100.0% from 53.07% recorded in Q1 2020.
  • In the past 5 years, Avadel Pharmaceuticals' Operating Margin registered a high of 399.06% during Q2 2020, and its lowest value of 360.52% during Q4 2018.
  • For the 5-year period, Avadel Pharmaceuticals' Operating Margin averaged around 7.71%, with its median value being 27.25% (2019).
  • As far as peak fluctuations go, Avadel Pharmaceuticals' Operating Margin crashed by -50912500bps in 2016, and later soared by 4244100bps in 2020.
  • Quarter analysis of 5 years shows Avadel Pharmaceuticals' Operating Margin stood at 39.61% in 2016, then crashed by -130bps to 11.74% in 2017, then tumbled by -2971bps to 360.52% in 2018, then skyrocketed by 81bps to 66.82% in 2019, then surged by 697bps to 399.06% in 2020.
  • Its last three reported values are 399.06% in Q2 2020, 53.07% for Q1 2020, and 66.82% during Q4 2019.